New drug shows promise for heart attack recovery in early trial
Disease control
Completed
This study tested a new medicine called CDR132L in 294 people who had a recent heart attack and had weak heart pumping function. The goal was to see if the drug could safely improve heart function over 6 months, compared to a placebo. All participants continued their standard hea…
Phase: PHASE2 • Sponsor: Cardior Pharmaceuticals GmbH • Aim: Disease control
Last updated May 12, 2026 13:41 UTC